Alliance Foundation Trials, Llc.
Clinical trials sponsored by Alliance Foundation Trials, Llc., explained in plain language.
-
New combo treatment aims to keep aggressive lung cancer from returning after surgery
Disease control Recruiting nowThis study is testing if adding an immunotherapy drug (durvalumab) to standard chemotherapy after surgery helps keep early-stage small cell lung cancer from coming back. It will enroll about 65 adults whose cancer was completely removed by surgery. The main goal is to see if this…
Phase: PHASE2 • Sponsor: Alliance Foundation Trials, LLC. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Scientists test custom drug cocktails to fight returning uterine cancer
Disease control Recruiting nowThis study is testing whether matching drug combinations to a patient's specific tumor genetics can better control recurrent endometrial cancer. It will enroll about 148 women whose cancer has returned after initial treatment. Doctors will analyze each tumor's genetic profile and…
Phase: PHASE1, PHASE2 • Sponsor: Alliance Foundation Trials, LLC. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New study aims to ease the financial burden of cancer care
Symptom relief Recruiting nowThis study is testing whether a monthly check-in about money problems can help people with advanced cancer. It aims to connect 1,000 eligible patients to financial support resources. The goal is to see if this reduces financial worry, improves quality of life, and helps people st…
Phase: NA • Sponsor: Alliance Foundation Trials, LLC. • Aim: Symptom relief
Last updated Mar 23, 2026 15:19 UTC